ATE225646T1 - Perkutan verabreichbare basiszusammensetzung und daraus hergestellte zusammensetzung - Google Patents

Perkutan verabreichbare basiszusammensetzung und daraus hergestellte zusammensetzung

Info

Publication number
ATE225646T1
ATE225646T1 AT93916216T AT93916216T ATE225646T1 AT E225646 T1 ATE225646 T1 AT E225646T1 AT 93916216 T AT93916216 T AT 93916216T AT 93916216 T AT93916216 T AT 93916216T AT E225646 T1 ATE225646 T1 AT E225646T1
Authority
AT
Austria
Prior art keywords
composition
percutaneously
administerable
drug
produced therefrom
Prior art date
Application number
AT93916216T
Other languages
English (en)
Inventor
Naruhito Higo
Yukio Kojima
Ken Komori
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE225646T1 publication Critical patent/ATE225646T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Seasonings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT93916216T 1992-07-23 1993-07-23 Perkutan verabreichbare basiszusammensetzung und daraus hergestellte zusammensetzung ATE225646T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP21836992 1992-07-23
JP22922692 1992-08-04
PCT/JP1993/001034 WO1994002119A1 (en) 1992-07-23 1993-07-23 Percutaneously administrable base composition and drug composition prepared therefrom

Publications (1)

Publication Number Publication Date
ATE225646T1 true ATE225646T1 (de) 2002-10-15

Family

ID=26522528

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93916216T ATE225646T1 (de) 1992-07-23 1993-07-23 Perkutan verabreichbare basiszusammensetzung und daraus hergestellte zusammensetzung

Country Status (9)

Country Link
US (1) US5932227A (de)
EP (1) EP0651993B1 (de)
CN (1) CN1076972C (de)
AT (1) ATE225646T1 (de)
AU (1) AU4585493A (de)
CA (1) CA2140901A1 (de)
DE (1) DE69332378T2 (de)
ES (1) ES2180546T3 (de)
WO (1) WO1994002119A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2753800B2 (ja) * 1994-04-14 1998-05-20 日東電工株式会社 経皮吸収型製剤
AU2266995A (en) * 1994-04-21 1995-11-16 Hisamitsu Pharmaceutical Co., Inc. Percutaneously administrable base composition and percutaneously administrable drug composition prepared therefrom
EP0747092B1 (de) * 1995-06-09 2003-12-03 Hisamitsu Pharmaceutical Co., Inc. Matrix für Iontophorese
IT1309588B1 (it) * 1999-03-05 2002-01-24 Altergon Sa Cerotto con spessore sottile contenente betametasone ed acidoialuronico per il trattamento di psoriasi, dermatite, dermatosi.
DE19950066A1 (de) * 1999-10-16 2001-04-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
JP4387639B2 (ja) * 2002-07-16 2009-12-16 久光製薬株式会社 経皮吸収製剤
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
GB0417675D0 (en) * 2004-08-09 2004-09-08 Futura Medical Dev Ltd Composition for promoting vascular smooth muscle relaxation
WO2006085521A1 (ja) * 2005-02-10 2006-08-17 Nihon University オピオイドレセプター拮抗剤を含有する経皮吸収用医薬組成物およびその製造方法、並びに前記拮抗剤の経皮吸収促進方法
US7655700B2 (en) 2005-08-25 2010-02-02 Michigan State University Transgenic mouse model and methods for treatment of neuro muscular disease by interfering with androgen-androgen receptor interaction in skeletal muscles
DK1937276T3 (da) 2005-10-12 2013-02-11 Besins Healthcare Luxembourg Forbedret testosterongel og fremgangsmåde til anvendelse deraf
GB0602224D0 (en) * 2006-02-03 2006-03-15 Futura Medical Dev Ltd Composition for promoting vascular smooth muscle relaxation
RU2699674C1 (ru) * 2015-09-30 2019-09-09 Фуджифилм Корпорэйшн Композиция для чрескожной абсорбции

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
DE3406497A1 (de) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
JPH0725669B2 (ja) * 1988-12-23 1995-03-22 日東電工株式会社 経皮投与用医薬製剤
DE4002281A1 (de) * 1990-01-26 1991-08-01 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit dem wirkstoff tulobuterol
MX9101787A (es) * 1990-10-29 1992-06-05 Alza Corp Formulaciones,metodos y dispositivos anticonceptivos transdermicos

Also Published As

Publication number Publication date
DE69332378D1 (de) 2002-11-14
DE69332378T2 (de) 2003-07-10
EP0651993A4 (de) 1997-02-26
AU4585493A (en) 1994-02-14
CA2140901A1 (en) 1994-02-05
US5932227A (en) 1999-08-03
ES2180546T3 (es) 2003-02-16
EP0651993B1 (de) 2002-10-09
CN1089507A (zh) 1994-07-20
EP0651993A1 (de) 1995-05-10
WO1994002119A1 (en) 1994-02-03
CN1076972C (zh) 2002-01-02

Similar Documents

Publication Publication Date Title
ATE225646T1 (de) Perkutan verabreichbare basiszusammensetzung und daraus hergestellte zusammensetzung
NO891379L (no) Anestetisk hudfuktingspreparat og fremgangsmaate for fremstilling derav.
KR880010764A (ko) 과콜레스테롤혈중 치료용 혼합물
EP0724885A4 (de) Pernasale zusammensetzung und diese enthaltende pernasale zubereitung
KR910009256A (ko) 식욕감소를 위한 조성물 및 그 방법
KR920002144A (ko) 아연 l-카르노신 염 또는 이의 착화합물을 유효성분으로 함유하는 염증성 장질환 예방 및 치료제
KR960700061A (ko) 니코틴 의존상태 치료를 위한 약리학적 제형 (pharmaceutical composition for treating nicotine dependence)
NO954691D0 (no) Reduksjon av liposom-indusert ugunstige fysiologiske reaksjoner
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
ATE206914T1 (de) Verwendung von ursolsäure zur herstellung eines arzneimittels zur unterdrückung von metastasen
KR890003391A (ko) 칼슘 보충제
KR890006227A (ko) 페놀-함유 진해성 액체 조성물
Yanagita Intravenous self-administration of (−)-cathinone and 2-amino-1-(2, 5-dimethoxy-4-methyl) phenylpropane in rhesus monkeys
EP0535237A4 (en) Composition for relieving skin irritation and external preparation for percutaneous adminstration containing the same
ES2052000T3 (es) Procedimiento para preparar composiciones farmaceuticas que contienen pentamidina.
ZA91115B (en) Topical compositions
KR930003913A (ko) 덱스트로메토르판의 진해효과를 증진시키기 위한 방법 및 약제학적 조성물
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
NZ225907A (en) Pharmaceutical carrier with enhanced percutaneous permeation comprising ethanol, water, propylene glycol and azone
GB2258397A (en) Pharmaceutical compositions containing amethocaine
DE68910010D1 (de) Verwendung von Dapiprazol zur Herstellung eines Arzneimittels zur Verhinderung des Toleranzentwicklung bei der analgetischen Behandlung mit Morphin.
KR890007728A (ko) 진통제 제조방법
KR970061084A (ko) 닭의 발육을 촉진하는 방법
Isaac et al. Does combining stimulants combine stimulation?
DE3786168D1 (de) Verwendung von para-aminobenzoesaeure zur herstellung eines arzneimittels zur bekaempfung von photoallergien.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0651993

Country of ref document: EP

REN Ceased due to non-payment of the annual fee